Coldwater Creek Inc. (NASDAQ: CWTR) stock plunged 20.20% to $3.99. The company announced today that the Company will be presenting at The 15th Annual ICR XChange Conference held at The Fontainebleau Miami Beach in Miami Beach, Florida, on Wednesday, January 16, 2013 at 1:35 p.m. Eastern Standard Time. Jill Dean, President and Chief Executive Officer, and Jim Bell, Executive Vice President, Chief Operating Officer and Chief Financial Officer, will host the presentation.
Additionally, the company updated its fourth quarter earnings guidance on Monday. The company provided EPS guidance of ($0.85)-(0.70) for the period, compared to the consensus EPS estimate of ($0.61).
Will CWTR Move Higher After Todays Sudden Selling Activities? Dont Miss The Free Trend Analysis here http://beststocksdaily.com/p2/index.php?company=CWTR
Capstone Turbine Corporation (NASDAQ: CPST) shares declined 6.88% to $0.801. The 52 week trading range for the company is $0.86 - $1.53. The shares of the company fell 25% in the last one year. The company develops small turbine generator sets. The Company's turbines can be fueled by natural gas, diesel, propane or gasoline.]
How Should Investors Trade CPST After The Recent Momentum, Find Out Here http://beststocksdaily.com/p2/index.php?company=CPST
Hemispherx BioPharma, Inc(NYSEAMEX: HEB) shares decreased 4.18% to $0.264. On Jan. 4, The Rosen Law Firm reminds investors of the important February 22, 2013 lead plaintiff deadline in the class action filed on behalf of investors who purchased the securities of Hemispherx Biopharma, Inc., (NYSE: HEB) from March 19, 2012 through December 17, 2012.
Additionally, on Dec. 29, Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Hemispherx Biopharma. The investigation focuses on whether the Company and its executives violated federal securities laws by issuing a series of materially false and misleading statements regarding the efficacy of Hemispherx's lead product, Ampligen(R) ("Ampligen"), a drug intended for the treatment of Myalgic Encephalomylitis/Chronic Fatigue Syndrome.
Get Free Special Trend Analysis On HEB Here http://beststocksdaily.com/p2/index.php?company=HEB
DryShips Inc. (NASDAQ: DRYS) shares fell 3.22% to $2.04. DRYS, through its majority owned subsidiary, Ocean Rig UDW Inc., or Ocean Rig, of offshore deepwater drilling services, recently announced the sale, via novation, of two of its tankers under construction at Samsung Heavy Industries, Esperona and Blanca, to a third-party buyer. Under the terms of the two novation agreements dated December 27, 2012, the buyer assumes all rights, benefits, liabilities and obligations under both shipbuilding contracts, in exchange for cash consideration of $21.4 million (that is, $10.7 million for each vessel) paid by the Company to the Buyer.
Get Free Special Trend Analysis On DRYS Here http://beststocksdaily.com/p2/index.php?company=DRYS
Lululemon Athletica inc. (NASDAQ:LULU) stock dropped 6.71% to $ 67.50 after the company announced that it now anticipates fourth quarter revenue will be at the high end of its original guidance range of $475 million to $480 million. The Company now expects diluted EPS will be $0.74, compared to previous guidance of 0.71 to $0.73.
Get Free Special Trend Analysis On LULU Here http://beststocksdaily.com/p2/index.php?company=LULU
Beststocksdailys team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdailys instant stock news on Major Gainers, Hot Stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.
The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
1419 Westwood Blvd Los Angeles, CA